Ledger.Open graph →
SEC Form D · filed June 8, 2020

C2i Genomics, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Ezra Sofer · Cresskill, NJExec · DirectorAsaf Zviran · Closter, NJExec · DirectorShaun Rodriguez · New York, NYDirectorEli Casdin · New York, NYDirectorSuneil Jhamb · MILL VALLEY, CADirectorJohn Schveibinz · Columbia, MDDirectorJoseph Harsanyi · Columbia, MDExec · DirectorJeremy Kaufman · Columbia, MDExec · DirectorOmri Amirav-Drori · San Francisco, CADirectorJose M. Sosa Del Valle · New York, NYDirectorKirk M. Beaton · New York, NYExec · DirectorVictor L. Wu · New York, NYExec · DirectorLee J. Tesconi · New York, NYDirectorOmri Amirav-Drori · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗